Core Viewpoint - The company plans to repurchase shares using its own funds ranging from RMB 25 million to 50 million, aimed at employee stock ownership plans or equity incentives [2] Group 1: Share Repurchase Plan - The company intends to repurchase shares at a price not exceeding RMB 6.22 per share, estimating the number of shares to be repurchased between 4,019,293 and 8,038,585, which represents approximately 0.72% to 1.45% of the total issued share capital [2] - The repurchase period is set for 12 months from the date of the board's approval [2] - If the company does not implement the equity incentive or employee stock ownership plan within 36 months after the repurchase, it will cancel the repurchased shares [2] Group 2: Implementation Status - As of the announcement date, the company has repurchased a total of 7,519,700 shares, accounting for 1.35% of the total share capital, with the highest transaction price at RMB 4.35 per share and the lowest at RMB 3.038 per share, totaling RMB 30,000,000 [3] - The actual execution of the repurchase aligns with the board-approved plan, with the total repurchase amount meeting the lower limit of the planned range [3] Group 3: Impact of Share Repurchase - The repurchase is expected to enhance the company's long-term incentive mechanism, protect shareholder rights, and boost investor confidence without significantly affecting the company's operations, finances, or future development [3] - The repurchase will not alter the company's control or its status as a listed company [3] Group 4: Shareholder Transactions - The chairman and actual controller of the company engaged in stock transactions during the repurchase period, with one instance of a family member mistakenly buying and selling shares [4] - Other executives and major shareholders did not engage in stock transactions during the specified period [5] Group 5: Expected Changes in Share Structure - The repurchase of 7,519,700 shares may lead to a change in the share structure, with the proportion of unrestricted circulating shares decreasing from 83.11% to 81.19% post-repurchase [5] Group 6: Compliance and Future Arrangements - The repurchase adheres to relevant regulations and guidelines set by the Shenzhen Stock Exchange [6] - The repurchased shares will be held in a special account and will not carry voting rights or other shareholder privileges during the holding period [6]

Core Viewpoint - The article discusses the complexities of equity structure in modern enterprises, emphasizing the need for a balance between team motivation, stable development, and founder control retention. Equity Structure Design - The premise of equity design is "same share, same right" [1] - Different voting rights and decision-making mechanisms exist between the board of directors and the shareholders' meeting, with a "one person, one vote" system typically applied [2] - Control rights are categorized as follows: - 67% absolute control (amend company articles, increase capital) - 51% relative control (major decision voting) - 34% veto power - 20% defined competitive power - 10% dissolution rights - 5% shareholding changes affecting listing - 3% proposal rights [3] Board of Directors - Board members are elected by the shareholders' meeting and are accountable to it, with specific voting thresholds for decision-making [4] Founder Considerations - Founders must consider how to prevent control dilution during financing, which involves complex, personalized design [5] Employee Equity Incentives - Key aspects of employee equity incentives include fairness across different positions and sustained motivation post-acquisition of equity: - Excess profit incentive method - Virtual stock with on-the-job dividends - Gradual registration stock incentive method - Option stock incentive [6][7] Investor Considerations - Investors prioritize capital rights, with shareholding ratios varying by funding stage: - Seed stage (5%-10%, valuation between 3 million to 6 million) - Angel round (10%-20%, valuation between 10 million to 50 million) [8][9] - Voting rights often include veto rights and protective clauses due to safety concerns and trust issues with founding teams [10] - Priority rights include preferential dividend rights, anti-dilution rights, and other special rights to ensure quick capital entry and exit [11] Course Offerings - The article promotes a course on equity design covering the entire lifecycle from initial setup to exit strategies, with practical case studies and strategies for control stability [12][13]

Summary of Key Points Core Viewpoint - The company, Shanghai Ziyan Food Co., Ltd., announced the repurchase and cancellation of 746,750 restricted stocks due to the departure of five incentive targets and the failure to meet performance targets for the first release period of the 2024 restricted stock incentive plan [1][2][3]. Group 1: Reasons for Repurchase and Cancellation - The repurchase and cancellation of restricted stocks were necessitated by the departure of five incentive targets who no longer qualified for the incentive program [3]. - The company did not meet the performance assessment targets for the first release period, with a revenue growth rate of -5.28% and a net profit growth rate of 4.88%, resulting in a 0% release ratio for the incentive stocks [4][5]. Group 2: Details of the Repurchase and Cancellation - A total of 173 incentive targets are involved in this repurchase, with 746,750 stocks to be canceled, of which a portion is due to unmet performance targets [4][5]. - The company has set up a dedicated securities account for the repurchase and expects the cancellation to be completed by June 19, 2025, reducing the total share capital from 414,260,500 shares to 413,513,750 shares [5]. Group 3: Company Commitments and Legal Compliance - The company assures that the decision-making process and information disclosure regarding the repurchase comply with relevant laws and regulations, and there are no violations of the rights of incentive targets or creditors [6]. - The legal opinion confirms that the repurchase and cancellation process has followed necessary procedures and is in accordance with the company's incentive plan and applicable regulations [6].

Core Viewpoint - The company has successfully achieved the conditions for the first exercise period of the 2024 stock option incentive plan, allowing for the exercise of 6.0115 million stock options [1][8][14] Group 1: Incentive Plan Approval and Implementation - The stock option incentive plan has been approved and implemented following the necessary decision-making procedures and information disclosure [1][2] - The first exercise period for the stock options is set from May 31, 2024, to May 30, 2026, with a 50% exercise ratio [6][8] - The total number of stock options granted in the first round is 13.5 million, with an exercise price initially set at 5.95 yuan per share [5][6] Group 2: Exercise Conditions and Performance Targets - The performance targets for the first exercise period require a revenue increase of at least 11.43% from the previous year, with 2024 revenue projected at 2.687733 billion yuan [8][12] - The exercise conditions include the absence of negative audit opinions and compliance with legal regulations [7][13] Group 3: Adjustments and Notifications - The exercise price has been adjusted from 5.95 yuan to 5.94 yuan due to dividend distributions [5][6] - The company has publicly disclosed the list of incentive recipients and has not received any objections during the public notice period [2][12] Group 4: Monitoring and Legal Compliance - The supervisory board has verified that the incentive recipients meet all legal and regulatory requirements for participation in the stock option plan [12][14] - Independent financial advisors have confirmed that the conditions for the first exercise period have been met and that the necessary approvals have been obtained [14]

上海君澜律师事务所 上海君澜律师事务所 关于 中安科股份有限公司 关于中安科股份有限公司 注销、回购注销、行权及解除限售相关事项 之 法律意见书 二〇二五年五月 上海君澜律师事务所 法律意见书 注销、回购注销、行权及解除限售相关事项之 法律意见书 致：中安科股份有限公司 上海君澜律师事务所（以下简称"本所"）接受中安科股份有限公司（以 下简称"公司"或"中安科"）的委托，根据《上市公司股权激励管理办法》 （以下简称"《管理办法》"）《中安科股份有限公司 2023 年股票期权与限制 性股票激励计划》（以下简称"《激励计划》"或"本次激励计划"）的规定， 就中安科本次激励计划注销部分股票期权、回购注销部分限制性股票、股票期 权第二期行权条件及限制性股票首次授予第二期及预留授予第一期解除限售条 件成就相关事项（以下简称"本次注销、回购注销、行权及解除限售"）相关 事项出具本法律意见书。 对本法律意见书，本所律师声明如下： （一）本所律师依据《中华人民共和国证券法》《律师事务所从事证券法 律业务管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定及 本法律意见书出具日以前已经发生或者存在的事实，严格履行了法定 ...

Core Viewpoint - The company announced the cancellation of certain stock options due to unmet performance conditions and the departure of some incentive recipients, impacting the 2022 stock option incentive plan [1][14][16]. Summary by Sections Stock Option Incentive Plan Overview - The 2022 stock option incentive plan was approved at the first extraordinary general meeting, allowing for a total of 33,000,000 stock options to be granted [1][4]. - The plan includes four exercise periods with specific performance targets based on net profit growth from 2021 [1][3]. Performance Conditions - For the first exercise period, the net profit growth rate must be at least 24% for 2022; for the second, at least 66% for 2023; for the third, at least 180% for 2025 [2][3]. - If the performance targets are not met, the corresponding stock options will be canceled [3][14]. Adjustments and Cancellations - Due to the departure of 23 recipients and performance issues, a total of 31,593,126 stock options will be canceled, including 2,657,855 options from departing recipients and 28,935,271 options due to unmet performance conditions [14][16]. - The exercise price for the stock options has been adjusted multiple times, currently set at 5.67 yuan per share [12][14]. Impact on the Company - The cancellation of stock options is not expected to affect the implementation of the 2022 incentive plan or the stability of the core management team, nor will it have a substantial impact on the company's financial status and operational results [14][15]. Legal and Procedural Compliance - The company has ensured that the cancellation process complies with relevant laws and regulations, and necessary approvals have been obtained [16][17].

Core Viewpoint - The Supervisory Board of Keda Intelligent Technology Co., Ltd. has verified the eligibility and compliance of the company's 2025 Restricted Stock Incentive Plan, concluding that the plan meets all relevant legal and regulatory requirements [1][2][3] Group 1: Eligibility and Compliance - The company has the necessary qualifications to implement the stock incentive plan, as it has not received negative or unqualified audit opinions on its financial reports or internal controls in the last fiscal year [1][2] - The incentive plan does not include independent directors, supervisors, foreign personnel, or shareholders holding more than 5% of the company's shares, ensuring compliance with the relevant regulations [2][3] - The granting and vesting arrangements for the restricted stocks do not violate any laws or regulations and do not infringe on the interests of the company and its shareholders [3] Group 2: Implementation Process - The relevant proposals of the incentive plan must be submitted for approval at the company's shareholders' meeting before implementation [3] - The company will publicly disclose the names and positions of the incentive plan participants at least 10 days prior to the shareholders' meeting [2]

证券代码：603893 证券简称：瑞芯微 公告编号：2025-051 ? 回购注销原因：瑞芯微电子股份有限公司（以下简称"公司"）2022 年 股票期权与限制性股票激励计划首次授予限制性股票第三个限售期的公司层面 业绩考核未达标，解除限售条件未成就，公司董事会同意对 2022 年股票期权与 限制性股票激励计划首次授予的 3 名激励对象第三个限售期未达到解除限售条 件的 28,000 股限制性股票进行回购注销。 ? 本次注销股份的有关情况 瑞芯微电子股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、本次限制性股票回购注销的决策与信息披露 第四次会议，审议通过《关于 2022 年股票期权与限制性股票激励计划首次授予 第三个行权期行权条件及第三个限售期解除限售条件未成就暨注销股票期权和 回购注销限制性股票的议案》。鉴于公司 2022 年股票期权与限制性股票激励计 划首次授予限制性股票第三个限售期的公司层面业绩考核未达标，解除限售条件 未成就，公司董事会审议决定回购注销 2022 年股票期权与限制性股票 ...

Summary of Key Points Core Viewpoint - The company has publicly announced the list of individuals who will be granted restricted stock under its first A-share incentive plan, confirming that all selected individuals meet the necessary qualifications and conditions as per relevant regulations and internal guidelines [1][2]. Disclosure Situation - The company conducted an internal public announcement from May 30, 2025, to June 8, 2025, regarding the names and positions of 158 individuals selected for the initial grant of restricted stock. No objections were raised during the public announcement period [1]. Verification Opinion - The supervisory board of the company has verified that the selected individuals meet the criteria set forth in the relevant laws, regulations, and the company's incentive plan. There are no disqualifications as per the applicable guidelines, and none of the selected individuals are independent directors, supervisors, or major shareholders [2].

Core Viewpoint - Nanjing Novogene Bioinformatics Technology Co., Ltd. plans to repurchase its shares through centralized bidding, with a total repurchase amount ranging from RMB 5 million to RMB 10 million, aimed at implementing equity incentives or employee stock ownership plans [1][4][6]. Summary by Relevant Sections Repurchase Plan Details - The repurchase amount is set between RMB 5 million and RMB 10 million [1][4]. - The funding source for the repurchase will be the company's own funds [1][4]. - The maximum repurchase price is capped at RMB 30 per share, which does not exceed 150% of the average trading price over the last 30 trading days prior to the board's decision [1][4][6]. - The repurchase will be conducted through the Shanghai Stock Exchange's trading system [1][5]. - The duration for the repurchase is within 12 months from the board's approval date [1][4]. Purpose and Use of Repurchased Shares - The repurchased shares will be used for implementing equity incentives or employee stock ownership plans [1][4][8]. - If the company fails to implement these plans within three years after the repurchase, the unutilized shares will be canceled [1][4][12]. Shareholder and Management Plans - Major shareholders, including the actual controller and board members, have no plans to reduce their holdings in the next three to six months [2][10][11]. - The proposal for the repurchase was initiated by the actual controller and chairman, Mr. Cao Lin, based on confidence in the company's future development [12][13]. Financial Impact and Structure Changes - As of March 31, 2025, the company's total assets were RMB 5.266 billion, with net assets attributable to shareholders at RMB 3.901 billion [8]. - The repurchase amount, if at the upper limit of RMB 10 million, would represent approximately 0.02% of total assets and 0.26% of net assets [8]. - The repurchase is expected to have no significant impact on the company's operations, financial status, or future development [8]. Compliance and Authorization - The repurchase plan has been approved by more than two-thirds of the board members and does not require shareholder meeting approval [3][4]. - The management is authorized to handle all matters related to the repurchase, including adjustments to the plan as necessary [13][14].